217 related articles for article (PubMed ID: 15808188)
1. Corneal sensitivity changes following the instillation of latanoprost, bimatoprost, and travoprost eyedrops.
Kozobolis VP; Detorakis ET; Maskaleris G; Koukoula SC; Fountoulakis N; Chrysochoou F; Konstas AG
Am J Ophthalmol; 2005 Apr; 139(4):742-3. PubMed ID: 15808188
[TBL] [Abstract][Full Text] [Related]
2. The effect of latanoprost, bimatoprost, and travoprost on circadian variation of intraocular pressure in patients with open-angle glaucoma.
Yildirim N; Sahin A; Gultekin S
J Glaucoma; 2008; 17(1):36-9. PubMed ID: 18303382
[TBL] [Abstract][Full Text] [Related]
3. Bimatoprost and travoprost: a review of recent studies of two new glaucoma drugs.
Eisenberg DL; Toris CB; Camras CB
Surv Ophthalmol; 2002 Aug; 47 Suppl 1():S105-15. PubMed ID: 12204706
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the effects of latanoprost, travoprost, and bimatoprost on circadian intraocular pressure in patients with glaucoma or ocular hypertension.
Orzalesi N; Rossetti L; Bottoli A; Fogagnolo P
Ophthalmology; 2006 Feb; 113(2):239-46. PubMed ID: 16458092
[TBL] [Abstract][Full Text] [Related]
5. Feasibility and efficacy of a mass switch from latanoprost to bimatoprost in glaucoma patients in a prepaid Health Maintenance Organization.
Law SK; Song BJ; Fang E; Caprioli J
Ophthalmology; 2005 Dec; 112(12):2123-30. PubMed ID: 16225924
[TBL] [Abstract][Full Text] [Related]
6. Comparison of corneal and conjunctival changes after dosing of travoprost preserved with sofZia, latanoprost with 0.02% benzalkonium chloride, and preservative-free artificial tears.
Kahook MY; Noecker RJ
Cornea; 2008 Apr; 27(3):339-43. PubMed ID: 18362664
[TBL] [Abstract][Full Text] [Related]
7. A 6-week, multicenter, randomized, double-masked, parallel-group study comparing travoprost 0.004% to latanoprost 0.005% followed by 6-week, open-label treatment with travoprost 0.004%.
Maul E; Carrasco FG; Costa VP; Casiraghi JF; Vargas E; Sarmina JS; Mayol R
Clin Ther; 2007 Sep; 29(9):1915-23. PubMed ID: 18035191
[TBL] [Abstract][Full Text] [Related]
8. A meta-analysis of topical prostaglandin analogues intra-ocular pressure lowering in glaucoma therapy.
Denis P; Lafuma A; Khoshnood B; Mimaud V; Berdeaux G
Curr Med Res Opin; 2007 Mar; 23(3):601-8. PubMed ID: 17355741
[TBL] [Abstract][Full Text] [Related]
9. Latanoprost therapy after sunken eyes caused by travoprost or bimatoprost.
Nakakura S; Tabuchi H; Kiuchi Y
Optom Vis Sci; 2011 Sep; 88(9):1140-4. PubMed ID: 21666524
[TBL] [Abstract][Full Text] [Related]
10. Circadian IOP-lowering efficacy of travoprost 0.004% ophthalmic solution compared to latanoprost 0.005%.
García-Feijoo J; Martínez-de-la-Casa JM; Castillo A; Méndez C; Fernández-Vidal A; García-Sánchez J
Curr Med Res Opin; 2006 Sep; 22(9):1689-97. PubMed ID: 16968572
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of switching from topical latanoprost to bimatoprost in patients with normal-tension glaucoma.
Sato S; Hirooka K; Baba T; Mizote M; Fujimura T; Tenkumo K; Ueda H; Shiraga F
J Ocul Pharmacol Ther; 2011 Oct; 27(5):499-502. PubMed ID: 21790301
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis of 24-hour intraocular pressure studies evaluating the efficacy of glaucoma medicines.
Stewart WC; Konstas AG; Nelson LA; Kruft B
Ophthalmology; 2008 Jul; 115(7):1117-1122.e1. PubMed ID: 18082886
[TBL] [Abstract][Full Text] [Related]
13. The effects of prostaglandin analogues on the blood aqueous barrier and corneal thickness of phakic patients with primary open-angle glaucoma and ocular hypertension.
Arcieri ES; Pierre Filho PT; Wakamatsu TH; Costa VP
Eye (Lond); 2008 Feb; 22(2):179-83. PubMed ID: 16936646
[TBL] [Abstract][Full Text] [Related]
14. The comparison of the effects of latanoprost, travoprost, and bimatoprost on central corneal thickness.
Zhong Y; Shen X; Yu J; Tan H; Cheng Y
Cornea; 2011 Aug; 30(8):861-4. PubMed ID: 21499083
[TBL] [Abstract][Full Text] [Related]
15. Conjunctival hyperemia in healthy subjects after short-term dosing with latanoprost, bimatoprost, and travoprost.
Stewart WC; Kolker AE; Stewart JA; Leech J; Jackson AL
Am J Ophthalmol; 2003 Mar; 135(3):314-20. PubMed ID: 12614748
[TBL] [Abstract][Full Text] [Related]
16. A 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0:005%/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.
Franks WA; Renard JP; Cunliffe IA; Rojanapongpun P
Clin Ther; 2006 Mar; 28(3):332-9. PubMed ID: 16750448
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of monotherapy treatment of glaucoma and ocular hypertension with the lipid class of medications.
Noecker RJ; Walt JG
Am J Ophthalmol; 2006 Jan; 141(1 Suppl):S15-21. PubMed ID: 16389056
[TBL] [Abstract][Full Text] [Related]
18. Twenty-four-hour intraocular pressure and blood pressure levels with bimatoprost versus latanoprost in patients with normal-tension glaucoma.
Quaranta L; Pizzolante T; Riva I; Haidich AB; Konstas AG; Stewart WC
Br J Ophthalmol; 2008 Sep; 92(9):1227-31. PubMed ID: 18586898
[TBL] [Abstract][Full Text] [Related]
19. Efficiency of instillation methods for prostaglandin medications.
Fiscella R; Wilensky JT; Chiang TH; Walt JG
J Ocul Pharmacol Ther; 2006 Dec; 22(6):477-82. PubMed ID: 17238816
[TBL] [Abstract][Full Text] [Related]
20. The effect of latanoprost, bimatoprost, and travoprost on intraocular pressure after cataract surgery.
Arici MK; Erdogan H; Toker I; Vural A; Topalkara A
J Ocul Pharmacol Ther; 2006 Feb; 22(1):34-40. PubMed ID: 16503773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]